Firdapse Found to be Effective for Lambert-Eaton Myasthenic Syndrome, Phase 3 Trial Shows
Firdapse led to clinically significant improvements, compared with a placebo, in adult patients with Lambert-Eaton myasthenic syndrome (LEMS), according to full results of a Phase 3 trial. The results were published in the Journal of Clinical Neuromuscular Disease in a study titled “Amifampridine Phosphate (Firdapse) Is Effective in…